0,888  0,003  Genotoxic
0,869  0,009  Transcription factor NF kappa B inhibitor
0,833  0,005  Mutagenic
0,829  0,004  Antioxidant
0,823  0,014  Apoptosis agonist
0,804  0,015  Antiinflammatory
0,779  0,004  Caspase 3 stimulant
0,767  0,004  Cardioprotectant
0,760  0,010  TNF expression inhibitor
0,761  0,016  Caspase 9 stimulant
0,725  0,004  Antimutagenic
0,697  0,005  Vascular (periferal) disease treatment
0,694  0,005  Tumour necrosis factor alpha release inhibitor
0,695  0,006  NOS2 expression inhibitor
0,698  0,014  Antineoplastic (colorectal cancer)
0,688  0,010  Antibacterial
0,684  0,007  UGT1A9 substrate
0,692  0,016  Teratogen
0,688  0,014  Antineoplastic (colon cancer)
0,675  0,004  Hepatoprotectant
0,679  0,010  Chemopreventive
0,670  0,006  Free radical scavenger
0,668  0,006  Hepatic disorders treatment
0,667  0,007  Nitric oxide antagonist
0,658  0,012  Chemoprotective
0,646  0,005  Apoptosis antagonist
0,658  0,018  Embryotoxic
0,652  0,018  Antileukemic
0,644  0,015  Carcinogenic
0,641  0,012  Antineoplastic (ovarian cancer)
0,623  0,004  Amylase inhibitor
0,617  0,002  Interleukin 12 antagonist
0,630  0,023  Antidiabetic
0,630  0,023  Cyclophilin D inhibitor
0,601  0,005  Antihypertriglyceridemic
0,612  0,029  Antineoplastic (lung cancer)
0,568  0,014  Proliferative diseases treatment
0,550  0,008  UGT1A1 substrate
0,544  0,015  NOS3 expression inhibitor
0,546  0,021  Antihypercholesterolemic
0,529  0,006  Melanin inhibitor
0,539  0,019  Sensitization
0,518  0,009  Antihypoxic
0,520  0,014  Hypoglycemic
0,511  0,006  Non-steroidal antiinflammatory agent
0,508  0,008  Antiulcerative
0,519  0,019  Antifungal
0,500  0,004  Antitussive
0,505  0,012  UGT1A6 substrate
0,536  0,046  Antineoplastic (breast cancer)
0,491  0,005  Lipid peroxidase inhibitor
0,492  0,007  Topoisomerase II inhibitor
0,493  0,011  RNA-directed DNA polymerase inhibitor
0,493  0,012  Antineoplastic (osteosarcoma)
0,501  0,024  Cytotoxic
0,512  0,038  CYP3A4 substrate
0,485  0,021  Antineoplastic (glioma)
0,493  0,030  Immunostimulant
0,507  0,054  Antiarthritic
0,461  0,014  Antineoplastic enhancer
0,448  0,005  Antineoplastic antibiotic
0,448  0,006  Alkylator
0,453  0,017  Antidiabetic symptomatic
0,442  0,009  Antineoplastic (squamous cell carcinoma)
0,448  0,015  UDP-glucuronosyltransferase substrate
0,441  0,010  Monophenol monooxygenase inhibitor
0,457  0,026  Antineoplastic (brain cancer)
0,450  0,020  Antineoplastic (glioblastoma multiforme)
0,435  0,005  Diabetic nephropathy treatment
0,457  0,027  AR expression inhibitor
0,440  0,013  Antineoplastic (small cell lung cancer)
0,451  0,027  Antiosteoporotic
0,447  0,024  ICAM1 expression inhibitor
0,432  0,010  Carcinogenic, group 3
0,432  0,010  Skin whitener
0,459  0,040  Prostate cancer treatment
0,454  0,036  Bone diseases treatment
0,429  0,014  Wound healing agent
0,420  0,007  Sulfotransferase substrate
0,426  0,013  Antineoplastic (sarcoma)
0,436  0,028  Cytostatic
0,453  0,048  Antipruritic, allergic
0,408  0,005  Neurotrophic factor enhancer
0,430  0,035  Antineoplastic (melanoma)
0,403  0,008  Protein kinase stimulant
0,392  0,005  Antihemorrhagic
0,392  0,009  UGT2B15 substrate
0,408  0,029  UGT2B4 substrate
0,390  0,014  Antineoplastic (carcinoma)
0,402  0,030  Interleukin antagonist
0,394  0,023  Angiogenesis stimulant
0,406  0,039  Antimycobacterial
0,371  0,005  Topoisomerase II alpha inhibitor
0,421  0,056  Immunosuppressant
0,386  0,023  DNA synthesis inhibitor
0,369  0,009  Sepsis treatment
0,384  0,039  Antineoplastic (cervical cancer)
0,354  0,014  Interferon gamma antagonist
0,341  0,003  Transcription factor NF kappa B stimulant
0,344  0,008  Topoisomerase I inhibitor
0,366  0,030  Antiparasitic
0,378  0,044  Antineoplastic (pancreatic cancer)
0,341  0,007  Hexokinase inhibitor
0,346  0,014  Hair growth stimulant
0,368  0,039  Antineoplastic (non-small cell lung cancer)
0,338  0,012  Liver fibrosis treatment
0,344  0,019  UGT2B7 substrate
0,360  0,035  Antineoplastic (lymphoma)
0,330  0,006  Nitric-oxide synthase stimulant
0,368  0,044  CTGF expression inhibitor
0,343  0,036  Antineoplastic (liver cancer)
0,312  0,007  Xanthine oxidase inhibitor
0,341  0,038  Antineoplastic (renal cancer)
0,343  0,043  DNA damaging
0,408  0,111  Alpha-glucosidase inhibitor
0,348  0,051  CYP2C19 substrate
0,313  0,016  NOS3 expression enhancer
0,316  0,019  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,315  0,021  VCAM1 expression inhibitor
0,324  0,033  Antineoplastic (bladder cancer)
0,300  0,010  Cystathionine beta-synthase inhibitor
0,344  0,055  Lipoprotein disorders treatment
0,304  0,023  Peptidyltransferase inhibitor
0,290  0,011  Antifungal enhancer
0,301  0,030  UGT1A4 substrate
0,290  0,024  Antipruritic, non-allergic
0,331  0,073  Cholesterol antagonist
0,314  0,060  Antineoplastic (endocrine cancer)
0,267  0,014  Aldose reductase substrate
0,336  0,089  Ulceration
0,319  0,077  Antithrombotic
0,268  0,027  UGT1A3 substrate
0,304  0,064  Antituberculosic
0,276  0,037  Antihelmintic
0,247  0,008  Antirickettsial
0,241  0,005  Chronic obstructive bronchitis treatment
0,244  0,009  Antibiotic
0,246  0,014  ATPase inhibitor
0,270  0,043  Antihypotensive
0,287  0,061  Antipyretic
0,320  0,094  CYP2C9 substrate
0,242  0,017  DNA intercalator
0,280  0,059  Interleukin agonist
0,229  0,008  AMP-activated protein kinase stimulant
0,225  0,013  SULT1A1 substrate
0,284  0,074  Hypoxia-inducible factor 1 alpha inhibitor
0,225  0,021  DNA polymerase I inhibitor
0,213  0,018  Expectorant
0,273  0,082  CYP1A2 substrate
0,199  0,009  DNA repair enzyme inhibitor
0,201  0,011  Selectin antagonist
0,218  0,040  Antiviral (Herpes)
0,332  0,156  Antineoplastic (solid tumors)
0,194  0,023  Antifungal (Cryptococcus)
0,253  0,083  Radiosensitizer
0,209  0,040  Contraceptive
0,227  0,058  Antiviral (Influenza)
0,273  0,105  Sodium/bile acid cotransporter inhibitor
0,267  0,100  Interleukin 2 agonist
0,182  0,017  Photosensitizer
0,241  0,078  Antiprotozoal (Leishmania)
0,173  0,011  Ca2+-transporting ATPase inhibitor
0,175  0,014  Actinic keratosis treatment
0,177  0,017  Antineoplastic (uterine cancer)
0,281  0,122  Antineoplastic (non-Hodgkin's lymphoma)
0,219  0,060  Abortion inducer
0,166  0,013  Antiviral (Trachoma)
0,171  0,018  Antiviral (Influenza B)
0,162  0,010  Aldose reductase inhibitor
0,184  0,032  Antiviral (Hepatitis B)
0,179  0,028  Cyclooxygenase 3 inhibitor
0,174  0,029  Carcinogenic, group 2B
0,209  0,064  Insulin sensitizer
0,188  0,046  UGT2B9 substrate
0,241  0,098  Radioprotector
0,171  0,035  Cell adhesion inhibitor
0,155  0,021  Antispirochetal
0,203  0,070  Platelet adhesion inhibitor
0,193  0,061  Lipocortins synthesis antagonist
0,173  0,043  CF transmembrane conductance regulator agonist
0,182  0,053  Interleukin 6 antagonist
0,137  0,008  Antibiotic Glycopeptide-like
0,138  0,011  ATPase (Vacuolar H+) inhibitor
0,235  0,108  Antineoplastic (multiple myeloma)
0,172  0,046  SULT1A3 substrate
0,142  0,018  SULT1E1 substrate
0,135  0,013  Lipase inhibitor
0,127  0,006  Antimycoplasmal
0,211  0,091  Antineoplastic (lymphocytic leukemia)
0,292  0,174  5 Hydroxytryptamine release inhibitor
0,169  0,053  Antiacne
0,143  0,028  Beta glucuronidase inhibitor
0,126  0,013  T cell inhibitor
0,193  0,081  Pneumotoxic
0,172  0,062  Arachidonic acid antagonist
0,123  0,014  Antiviral (Dengue virus)
0,200  0,093  Antiviral (HIV)
0,107  0,003  Protein 30S ribosomal subunit inhibitor
0,120  0,016  Na+ K+ transporting ATPase inhibitor
0,160  0,057  Antiprotozoal (Coccidial)
0,106  0,003  Sodium/glucose cotransporter 2 inhibitor
0,141  0,038  Mucolytic
0,248  0,145  Stroke treatment
0,181  0,079  P-glycoprotein inhibitor
0,127  0,026  Thioredoxin inhibitor
0,149  0,048  Aldehyde dehydrogenase inhibitor
0,177  0,080  Antiviral (Hepatitis)
0,100  0,003  Antibiotic Aminoglycoside-like
0,132  0,038  Antineoplastic, alkylator
0,191  0,101  Hypolipemic
0,139  0,050  Growth stimulant
0,136  0,046  Glutathione S-transferase substrate
0,126  0,038  Toll-Like receptor 4 antagonist
0,128  0,042  Estrogen antagonist
0,089  0,003  Sodium/glucose cotransporter inhibitor
0,249  0,165  Antiprotozoal
0,218  0,134  Metabolic disease treatment
0,151  0,067  Hemostatic
0,119  0,035  UGT2B11 substrate
0,132  0,049  Alcohol dehydrogenase substrate
0,098  0,016  Neuraminidase inhibitor
0,113  0,031  NAD(P)H dehydrogenase (quinone) inhibitor
0,128  0,047  Choleretic
0,142  0,063  Farnesoid X receptor antagonist
0,093  0,015  Protein 50S ribosomal subunit inhibitor
0,139  0,061  Interleukin 4 antagonist
0,129  0,052  Microtubule formation inhibitor
0,141  0,066  Bone formation stimulant
0,094  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,083  0,010  Alpha-mannosidase inhibitor
0,079  0,007  Cholesterol esterase inhibitor
0,099  0,026  HIV-1 integrase (3'-Processing) inhibitor
0,202  0,131  Respiratory analeptic
0,118  0,050  UGT2B1 substrate
0,215  0,147  Immunomodulator
0,141  0,074  Cell wall synthesis inhibitor
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,095  0,030  CDC25A inhibitor
0,146  0,082  Eye irritation, high
0,124  0,061  Cholesterol synthesis inhibitor
0,097  0,035  Glycine receptor antagonist
0,158  0,099  Antineoplastic (bone cancer)
0,103  0,044  Carcinogenic, group 2A
0,113  0,054  5-Lipoxygenase inhibitor
0,109  0,051  Anabolic
0,133  0,076  Psychosexual dysfunction treatment
0,085  0,029  HIV-1 integrase (Strand Transfer) inhibitor
0,139  0,083  Antiviral (Influenza A)
0,108  0,052  UDP-glucose 4-epimerase inhibitor
0,067  0,013  Mannosidase inhibitor
0,123  0,069  Coagulant
0,173  0,121  Aldehyde oxidase inhibitor
0,126  0,074  Vanilloid 1 agonist
0,068  0,018  Topoisomerase II beta inhibitor
0,105  0,055  Estrogen receptor beta antagonist
0,053  0,004  Sodium/glucose cotransporter 1 inhibitor
0,090  0,041  Thioredoxin reductase inhibitor
0,050  0,002  Antibiotic Anthracycline-like
0,095  0,050  NADH dehydrogenase inhibitor
0,070  0,026  Estrogen agonist
0,107  0,063  Antiprotozoal (Toxoplasma)
0,147  0,105  UGT2B10 substrate
0,081  0,040  Antitreponemal
0,190  0,151  Lipoxygenase inhibitor
0,100  0,062  Carbonic anhydrase III inhibitor
0,126  0,090  Acaricide
0,146  0,110  Antineoplastic (gastric cancer)
0,091  0,055  Ornithine decarboxylase inhibitor
0,132  0,097  Acute respiratory distress syndrome (ARDS) treatment
0,064  0,029  Lipocortins synthesis agonist
0,113  0,079  Antiseptic
0,047  0,014  Cholesterol absorption inhibitor
0,063  0,030  Postmenopausal disorders treatment
0,043  0,011  ATP citrate lysase inhibitor
0,163  0,131  Cyclic AMP phosphodiesterase inhibitor
0,091  0,059  Triose-phosphate isomerase inhibitor
0,094  0,063  Antischistosomal
0,100  0,070  Mediator release inhibitor
0,068  0,040  CDC25B inhibitor
0,112  0,085  Antifungal (Pneumocystis)
0,129  0,103  Protein-tyrosine phosphatase inhibitor
0,057  0,032  Leukotriene B4 antagonist
0,059  0,037  Fatty acid synthase inhibitor
0,093  0,070  Dementia treatment
0,086  0,065  Contraceptive male
0,090  0,069  Vascular dementia treatment
0,101  0,081  Electron transport complex I inhibitor
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,021  0,004  Antibiotic Tetracycline-like
0,081  0,064  Antineoplastic alkaloid
0,208  0,193  Histamine release inhibitor
0,093  0,080  HDL-cholesterol increasing
0,120  0,107  Antidote
0,027  0,014  Vanilloid 2 agonist
0,042  0,030  DNA gyrase subunit A inhibitor
0,019  0,009  Telomerase stimulant
0,063  0,053  Phosphofructokinase-1 inhibitor
0,174  0,165  Antidiabetic (type 2)
0,072  0,064  Estrogen receptor alpha antagonist
0,048  0,044  Glucose-6-phosphate translocase inhibitor
0,068  0,065  SULT1A2 substrate
0,091  0,088  Protein-tyrosine phosphatase 1B inhibitor
0,084  0,081  Sphingomyelinase inhibitor
0,069  0,068  Keratolytic
0,191  0,190  Vasodilator, coronary
0,085  0,084  Skin irritative effect
0,012  0,011  Antibiotic Macrolide-like
0,102  0,102  Cyclooxygenase 2 inhibitor

